Trial Profile

A 12-Week Randomized, Double-Blind, Multicenter Pilot Study to Evaluate the Effect of Etanercept 100 mg and 50 mg Weekly in Subjects With Ankylosing Spondylitis

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 12 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etanercept (Primary)
Indications Ankylosing spondylitis
Focus Therapeutic Use
Acronyms LOADET
Sponsors Wyeth

Most Recent Events

08 Apr 2022 This trial has been completed (End Date: 06 Aug 2008), according to European Clinical Trials Database record.
16 Jun 2010 Results presented at 11th Annual Congress of the European League Against Rheumatism (EULAR) 2010
14 Aug 2009 Actual end date changed from Feb 2008 to Jun 2008 and actual number of patients (108) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com